David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.31% |
| 2 | Healthcare | 10.66% |
| 3 | Consumer Discretionary | 10.29% |
| 4 | Communication Services | 8.78% |
| 5 | Financials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JAX
2026
DELISTED
J. Alexander's Holdings, Inc.
JAX
| $1.92M | ﹤0.01% |
165,184
+5,499
| +3% | +$56.8K |
|
|
BRKL
2027
DELISTED
Brookline Bancorp
BRKL
| $1.92M | ﹤0.01% |
123,562
+49,384
| +67% | +$716K |
|
|
LDL
2028
DELISTED
Lydall, Inc.
LDL
| $1.92M | ﹤0.01% |
33,418
+28,555
| +587% | +$1.42M |
|
2029
ASE Group
ASX
$96.4B
| $1.91M | ﹤0.01% |
309,483
+87,351
| +39% | +$548K |
|
2030
PUT
Genuine Parts
GPC
$19.1B
| $1.91M | ﹤0.01% |
+20,000
| New | +$1.7M |
|
2031
Hilltop Holdings
HTH
$2.21B
| $1.91M | ﹤0.01% |
73,507
+38,121
| +108% | +$957K |
|
2032
State Street SPDR S&P Homebuilders ETF
XHB
$1.42B
| $1.91M | ﹤0.01% |
+48,000
| New | +$1.85M |
|
2033
CALL
Autodesk
ADSK
$53B
| $1.91M | ﹤0.01% |
17,000
+7,000
| +70% | +$772K |
|
2034
Vermilion Energy
VET
$1.88B
| $1.91M | ﹤0.01% |
53,661
-74,689
| -58% | -$2.46M |
|
2035
Consolidated Edison
ED
$39.9B
| $1.9M | ﹤0.01% |
+23,600
| New | +$1.95M |
|
2036
TechTarget
TTGT
$276M
| $1.9M | ﹤0.01% |
159,031
+4,967
| +3% | +$50.7K |
|
|
USAK
2037
DELISTED
USA Truck Inc
USAK
| $1.89M | ﹤0.01% |
134,784
+41,199
| +44% | +$418K |
|
2038
PUT
Check Point Software Technologies
CHKP
$13.1B
| $1.89M | ﹤0.01% |
16,600
| – | – |
|
2039
Altisource Portfolio Solutions
ASPS
$67.4M
| $1.88M | ﹤0.01% |
9,102
+7,585
| +500% | +$1.41M |
|
|
TSC
2040
DELISTED
TriState Capital Holdings, Inc.
TSC
| $1.88M | ﹤0.01% |
81,977
+6,036
| +8% | +$136K |
|
2041
TTM Technologies
TTMI
$12.8B
| $1.88M | ﹤0.01% |
122,042
-348,078
| -74% | -$5.42M |
|
2042
Urban Outfitters
URBN
$6.8B
| $1.88M | ﹤0.01% |
78,452
-195,945
| -71% | -$3.94M |
|
2043
Ubiquiti
UI
$35.3B
| $1.87M | ﹤0.01% |
33,461
-28,400
| -46% | -$1.64M |
|
|
PERY
2044
DELISTED
Perry Ellis International Inc
PERY
| $1.87M | ﹤0.01% |
79,156
+1,053
| +1% | +$21.4K |
|
|
RP
2045
DELISTED
RealPage, Inc.
RP
| $1.87M | ﹤0.01% |
46,927
-74,170
| -61% | -$2.96M |
|
2046
CALL
Cigna
CI
$74.8B
| $1.87M | ﹤0.01% |
10,000
| – | – |
|
|
2047
PUT
Cigna
CI
$74.8B
| $1.87M | ﹤0.01% |
10,000
| – | – |
|
|
SAGE
2048
CALL
DELISTED
Sage Therapeutics
SAGE
| $1.87M | ﹤0.01% |
30,000
+20,000
| +200% | +$1.57M |
|
2049
Caesars Entertainment
CZR
$6.04B
| $1.87M | ﹤0.01% |
72,796
+39,326
| +117% | +$874K |
|
|
CLDR
2050
DELISTED
Cloudera, Inc.
CLDR
| $1.87M | ﹤0.01% |
+112,272
| New | +$2M |
|
Similar funds
David Shaw's Q3 2017 Portfolio in Review
As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
- David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- David Shaw opened 469 new positions and closed 370 in Q3 2017.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.